Cornell Pochily Investment Advisors, Inc. Abb Vie Inc. Transaction History
Cornell Pochily Investment Advisors, Inc.
- $286 Million
- Q3 2024
A detailed history of Cornell Pochily Investment Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Cornell Pochily Investment Advisors, Inc. holds 27,305 shares of ABBV stock, worth $5.57 Million. This represents 1.89% of its overall portfolio holdings.
Number of Shares
27,305
Previous 27,452
0.54%
Holding current value
$5.57 Million
Previous $4.71 Million
14.53%
% of portfolio
1.89%
Previous 1.8%
Shares
28 transactions
Others Institutions Holding ABBV
# of Institutions
3,767Shares Held
1.28BCall Options Held
13MPut Options Held
9.83M-
Vanguard Group Inc Valley Forge, PA171MShares$34.8 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.8 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$15.9 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY53.6MShares$10.9 Billion0.81% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$7.87 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $360B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...